{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T17:43:01Z","timestamp":1792690981120,"version":"4.5.0"},"reference-count":86,"publisher":"Oxford University Press (OUP)","license":[{"start":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T00:00:00Z","timestamp":1792627200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Amyloid myopathy is an etiologically heterogeneous group of disorders associated with amyloid deposition in skeletal muscle. The great majority of cases reflect muscle involvement in systemic amyloidosis, particularly immunoglobulin light-chain amyloidosis and hereditary amyloidosis. Occasionally, amyloid myopathy presents as an isolated myopathy associated with muscle proteinopathies. Clinical manifestations are generally nonspecific. Muscle weakness is the most common presentation; however, many patients with biopsy-confirmed amyloid deposition lack objective weakness, as amyloid within muscle does not necessarily equate to clinically significant myopathy. Amyloid myopathy is probably underdiagnosed due to the limited use of muscle biopsies and potential under-detection of amyloid deposition in muscle specimens. Histopathologically, it is characterized by amyloid deposition predominantly within the perimysial and endomysial blood vessel walls and perivascular regions. Neurogenic features are also frequently observed in muscle biopsies from patients with systemic amyloidosis-associated or isolated myopathy. While amyloid microangiopathy and neurogenic features seem to dominate amyloid myopathy pathology, the pathogenesis remains elusive. In this article, we comprehensively review amyloid myopathy pathogenesis and histopathological correlates including specific workup for detection of amyloid deposition, as well as clinical manifestations, diagnostic approach, and management. This review reveals that amyloid myopathy may represent a microangiopathic-neurogenic-myopathic process.<\/jats:p>","DOI":"10.1093\/jnen\/nlag112","type":"journal-article","created":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T17:22:22Z","timestamp":1792689742000},"source":"Crossref","is-referenced-by-count":0,"title":["Amyloid myopathy: A primarily microangiopathic and neurogenic disease"],"prefix":"10.1093","author":[{"given":"Grace K","family":"Grafham","sequence":"first","affiliation":[{"name":"Department of Pathology and Molecular Medicine, McMaster University , Hamilton, Ontario,","place":["Canada"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hannah W","family":"Faris","sequence":"additional","affiliation":[{"name":"Department of Medicine (Neurology), McMaster University , Hamilton, Ontario,","place":["Canada"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chuanzhu","family":"Yan","sequence":"additional","affiliation":[{"name":"Department of Neurology, Qilu Hospital, Cheeloo College of Medicine, Shandong University , Jinan,","place":["China"]},{"name":"Research Institute of Neuromuscular and Neurodegenerative Diseases, Qilu Hospital, Cheeloo College of Medicine, Shandong University , Jinan,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0312-3746","authenticated-orcid":false,"given":"Mark A","family":"Tarnopolsky","sequence":"additional","affiliation":[{"name":"Department of Medicine (Neurology), McMaster University , Hamilton, Ontario,","place":["Canada"]},{"name":"Department of Pediatrics, McMaster University , Hamilton, Ontario,","place":["Canada"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1945-5569","authenticated-orcid":false,"given":"Jian-Qiang","family":"Lu","sequence":"additional","affiliation":[{"name":"Department of Pathology and Molecular Medicine, McMaster University , Hamilton, Ontario,","place":["Canada"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2026,10,22]]},"reference":[{"key":"2026102213221687500_nlag112-B1","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1001\/jama.2020.5493","article-title":"Systemic amyloidosis recognition, prognosis, and therapy: a systematic review","volume":"324","author":"Gertz","year":"2020","journal-title":"JAMA"},{"key":"2026102213221687500_nlag112-B2","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1080\/13506129.2024.2405948","article-title":"Amyloid nomenclature 2024: update, novel proteins, and recommendations by the International Society of Amyloidosis (ISA) nomenclature committee","volume":"31","author":"Buxbaum","year":"2024","journal-title":"Amyloid"},{"key":"2026102213221687500_nlag112-B3","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1002\/ana.26965","article-title":"Amyloid neuropathy: from pathophysiology to treatment in light-chain amyloidosis and hereditary transthyretin amyloidosis","volume":"96","author":"Chompoopong","year":"2024","journal-title":"Ann Neurol"},{"key":"2026102213221687500_nlag112-B4","doi-asserted-by":"publisher","first-page":"e12996","DOI":"10.1111\/nan.12996","article-title":"Skeletal muscle involvement in systemic amyloidosis is often overlooked","volume":"50","author":"Xu","year":"2024","journal-title":"Neuropathol Appl Neurobiol"},{"key":"2026102213221687500_nlag112-B5","doi-asserted-by":"publisher","first-page":"978","DOI":"10.1093\/jnen\/nlaf088","article-title":"Intracellular amyloidosis in peripheral nerve and skeletal muscle","volume":"84","author":"Grafham","year":"2025","journal-title":"J Neuropathol Exp Neurol"},{"key":"2026102213221687500_nlag112-B6","doi-asserted-by":"publisher","first-page":"1437","DOI":"10.1111\/ene.13448","article-title":"Characterization of isolated amyloid myopathy","volume":"24","author":"Liewluck","year":"2017","journal-title":"Eur J Neurol"},{"key":"2026102213221687500_nlag112-B7","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1002\/ana.21309","article-title":"Dysferlin-deficient muscular dystrophy features amyloidosis","volume":"63","author":"Spuler","year":"2008","journal-title":"Ann Neurol"},{"key":"2026102213221687500_nlag112-B8","doi-asserted-by":"publisher","first-page":"1186","DOI":"10.1136\/jnnp.2009.173823","article-title":"Inclusion body myositis: old and new concepts","volume":"80","author":"Amato","year":"2009","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"2026102213221687500_nlag112-B9","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1002\/1531-8249(200004)47:4&lt;544::AID-ANA24&gt;3.0.CO;2-D","article-title":"Inclusion body myositis, muscle blood vessel and cardiac amyloidosis, and transthyretin Val122Ile allele","volume":"47","author":"Askanas","year":"2000","journal-title":"Ann Neurol"},{"key":"2026102213221687500_nlag112-B10","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1080\/1744666X.2022.2054803","article-title":"Complement in autoimmune inflammatory myopathies, the role of myositis-associated antibodies, COVID-19 associations, and muscle amyloid deposits","volume":"18","author":"Dalakas","year":"2022","journal-title":"Expert Rev Clin Immunol"},{"key":"2026102213221687500_nlag112-B11","doi-asserted-by":"publisher","first-page":"1128","DOI":"10.1016\/s0046-8177(98)90425-7","article-title":"Rimmed vacuoles with beta-amyloid and ubiquitinated filamentous deposits in the muscles of patients with long-standing denervation (postpoliomyelitis muscular atrophy): similarities with inclusion body myositis","volume":"29","author":"Semino-Mora","year":"1998","journal-title":"Hum Pathol"},{"key":"2026102213221687500_nlag112-B12","doi-asserted-by":"publisher","first-page":"1366","DOI":"10.1093\/ndt\/gfac217","article-title":"AA amyloidosis associated with cancers","volume":"38","author":"Bharati","year":"2023","journal-title":"Nephrol Dial Transplant"},{"key":"2026102213221687500_nlag112-B13","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1002\/acn3.51930","article-title":"Nerve pathology of microangiopathy and thromboinflammation in hereditary transthyretin amyloidosis","volume":"11","author":"Yeh","year":"2024","journal-title":"Ann Clin Transl Neurol"},{"key":"2026102213221687500_nlag112-B14","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1002\/mus.27150","article-title":"Neuromuscular amyloidosis: unmasking the master of disguise","volume":"64","author":"Pinto","year":"2021","journal-title":"Muscle Nerve"},{"key":"2026102213221687500_nlag112-B15","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1093\/jnen\/61.6.565","article-title":"Neuromuscular pathology in hereditary gelsolin amyloidosis","volume":"61","author":"Kiuru-Enari","year":"2002","journal-title":"J Neuropathol Exp Neurol"},{"key":"2026102213221687500_nlag112-B16","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1111\/1346-8138.17562","article-title":"The evaluation of Congo red staining combined with fluorescence microscopy in the diagnosis of primary cutaneous amyloidosis","volume":"52","author":"Song","year":"2025","journal-title":"J Dermatol"},{"key":"2026102213221687500_nlag112-B17","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1186\/s13000-019-0822-4","article-title":"Improving sensitivity of amyloid detection by Congo red stain by using polarizing microscope and avoiding pitfalls","volume":"14","author":"El-Meanawy","year":"2019","journal-title":"Diagn Pathol"},{"key":"2026102213221687500_nlag112-B18","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/j.acthis.2006.03.017","article-title":"Sensitivity and specificity of Congo red staining according to Romh\u00e1nyi. Comparison with Puchtler\u2019s or Bennhold\u2019s methods","volume":"108","author":"B\u00e9ly","year":"2006","journal-title":"Acta Histochem"},{"key":"2026102213221687500_nlag112-B19","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1016\/j.micron.2008.10.002","article-title":"Optical properties of amyloid stained by Congo red: history and mechanisms","volume":"40","author":"Howie","year":"2009","journal-title":"Micron"},{"key":"2026102213221687500_nlag112-B20","doi-asserted-by":"publisher","first-page":"59","DOI":"10.5414\/npp29059","article-title":"Usefulness of combined nerve and muscle biopsy in the diagnosis of amyloid neuropathy\u2013a study of 6 new cases","volume":"29","author":"Vital","year":"2010","journal-title":"Clin Neuropathol"},{"key":"2026102213221687500_nlag112-B21","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1186\/s12883-024-03900-z","article-title":"Amyloid myopathy mimicked with idiopathic inflammatory myopathy diagnosed using Congo red staining: a case report","volume":"24","author":"Han","year":"2024","journal-title":"BMC Neurol"},{"key":"2026102213221687500_nlag112-B22","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1097\/cnd.0000000000000288","article-title":"Wild-type transthyretin amyloid myopathy with an inclusion body myositis phenotype","volume":"22","author":"Huser","year":"2020","journal-title":"J Clin Neuromuscul Dis"},{"key":"2026102213221687500_nlag112-B23","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1017\/S0317167100013846","article-title":"Amyloid myoneuropathy mimicking inclusion body myositis","volume":"40","author":"Abuzinadah","year":"2013","journal-title":"Can J Neurol Sci"},{"key":"2026102213221687500_nlag112-B24","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1002\/mus.20169","article-title":"Amyloid myopathy: characteristic features of a still underdiagnosed disease","volume":"31","author":"Chapin","year":"2005","journal-title":"Muscle Nerve"},{"key":"2026102213221687500_nlag112-B25","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1002\/ana.410430606","article-title":"Amyloid myopathy: an underdiagnosed entity","volume":"43","author":"Spuler","year":"1998","journal-title":"Ann Neurol"},{"key":"2026102213221687500_nlag112-B26","doi-asserted-by":"publisher","first-page":"2511","DOI":"10.1080\/07853890.2022.2123558","article-title":"Systematic review of accuracy of reporting of Congo red-stained amyloid in 2010\u20132020 compared with earlier","volume":"54","author":"Howie","year":"2022","journal-title":"Ann Med"},{"key":"2026102213221687500_nlag112-B27","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1002\/mus.20185","article-title":"Muscular amyloid angiopathy with amyloidgenic transthyretin Ser50Ile and Tyr114Cys","volume":"31","author":"Yamashita","year":"2005","journal-title":"Muscle Nerve"},{"key":"2026102213221687500_nlag112-B28","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1002\/mus.24563","article-title":"Amyloid polyneuropathy caused by wild-type transthyretin","volume":"52","author":"Lam","year":"2015","journal-title":"Muscle Nerve"},{"key":"2026102213221687500_nlag112-B29","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1002\/mus.23287","article-title":"Expanding the spectrum of monoclonal light chain deposition disease in muscle","volume":"45","author":"Ostrow","year":"2012","journal-title":"Muscle Nerve"},{"key":"2026102213221687500_nlag112-B30","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1002\/mus.20777","article-title":"Axial myopathy due to primary amyloidosis","volume":"36","author":"Friedman","year":"2007","journal-title":"Muscle Nerve"},{"key":"2026102213221687500_nlag112-B31","doi-asserted-by":"publisher","first-page":"200","DOI":"10.5114\/pjp.2018.76705","article-title":"Intraoral manifestation of systemic AL amyloidosis with unique microscopic presentation of intracellular amyloid deposition in striated muscles","volume":"69","author":"Oruba","year":"2018","journal-title":"Pol J Pathol"},{"key":"2026102213221687500_nlag112-B32","doi-asserted-by":"publisher","first-page":"1354","DOI":"10.1016\/j.mayocp.2016.06.027","article-title":"Systemic immunoglobulin light chain amyloidosis\u2013associated myopathy: presentation, diagnostic pitfalls, and outcome","volume":"91","author":"Muchtar","year":"2016","journal-title":"Mayo Clin Proc"},{"key":"2026102213221687500_nlag112-B33","doi-asserted-by":"publisher","first-page":"1457","DOI":"10.1007\/s10072-022-06538-2","article-title":"Unusual features of myositis with amyloid myopathy","volume":"44","author":"Gupta","year":"2023","journal-title":"Neurol Sci"},{"key":"2026102213221687500_nlag112-B34","doi-asserted-by":"publisher","first-page":"1420","DOI":"10.1007\/s12350-022-02990-x","article-title":"Amyloid myopathy: expanding the clinical spectrum of transthyretin amyloidosis\u2014case report and literature review","volume":"30","author":"Ungericht","year":"2023","journal-title":"J Nucl Cardiol"},{"key":"2026102213221687500_nlag112-B35","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/j.wneu.2023.06.037","article-title":"The emerging significance of amyloid deposits in the ligamentum flavum of spinal stenosis patients: a review","volume":"177","author":"Wang","year":"2023","journal-title":"World Neurosurg"},{"key":"2026102213221687500_nlag112-B36","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1038\/modpathol.2014.102","article-title":"Amyloid deposits derived from transthyretin in the ligamentum flavum as related to lumbar spinal canal stenosis","volume":"28","author":"Yanagisawa","year":"2015","journal-title":"Mod Pathol"},{"key":"2026102213221687500_nlag112-B37","doi-asserted-by":"publisher","first-page":"1289","DOI":"10.1093\/ehjci\/jeu107","article-title":"Utility and limitations of 3,3-diphosphono-1,2-propanodicarboxylic acid scintigraphy in systemic amyloidosis","volume":"15","author":"Hutt","year":"2014","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"2026102213221687500_nlag112-B38","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1016\/j.ophtha.2003.09.032","article-title":"Ptosis from localized A-\u03bb-amyloid deposits in the levator palpebrae muscle","volume":"111","author":"Dithmar","year":"2004","journal-title":"Ophthalmology"},{"key":"2026102213221687500_nlag112-B39","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1136\/jnnp-2021-327909","article-title":"Novel approaches to diagnosis and management of hereditary transthyretin amyloidosis","volume":"93","author":"Carroll","year":"2022","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"2026102213221687500_nlag112-B40","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines7010011","article-title":"Ultrastructure in transthyretin amyloidosis: from pathophysiology to therapeutic insights","volume":"7","author":"Koike","year":"2019","journal-title":"Biomedicines"},{"key":"2026102213221687500_nlag112-B41","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/0022-510X(88)90158-X","article-title":"Skeletal muscle amyloid deposition in AL- (primary or myeloma-associated), AA- (secondary), and prealbumin-type amyloidosis","volume":"85","author":"Yamada","year":"1988","journal-title":"J Neurolog Sci"},{"key":"2026102213221687500_nlag112-B42","doi-asserted-by":"publisher","first-page":"2099","DOI":"10.1007\/s13760-024-02607-9","article-title":"A case of mixed hereditary gelsolin amyloidosis and hydroxychloroquine induced myopathy","volume":"124","author":"Mak","year":"2024","journal-title":"Acta Neurol Belg"},{"key":"2026102213221687500_nlag112-B43","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1002\/mus.10474","article-title":"Gelsolin-related familial amyloidosis, Finnish type, in a Portuguese family: clinical and neurophysiological studies","volume":"28","author":"Concei\u00e7\u00e3o","year":"2003","journal-title":"Muscle Nerve"},{"key":"2026102213221687500_nlag112-B44","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/13506129.2019.1693359","article-title":"Causes of AA amyloidosis: a systematic review","volume":"27","author":"Brunger","year":"2020","journal-title":"Amyloid"},{"key":"2026102213221687500_nlag112-B45","first-page":"850","article-title":"Amyloid A amyloidosis secondary to rheumatoid arthritis: pathophysiology and treatments","volume":"29","author":"Nakamura","year":"2011","journal-title":"Clin Exp Rheumatol"},{"key":"2026102213221687500_nlag112-B46","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1002\/mus.24771","article-title":"Myopathy in a patient with systemic AA amyloidosis possibly induced by psoriasis vulgaris: an autopsy case","volume":"52","author":"Tanabe","year":"2015","journal-title":"Muscle Nerve"},{"key":"2026102213221687500_nlag112-B47","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1002\/mus.24302","article-title":"Novel ANO5 homozygous microdeletion causing myalgia and unprovoked rhabdomyolysis in an Arabic man","volume":"50","author":"Lahoria","year":"2014","journal-title":"Muscle Nerve"},{"key":"2026102213221687500_nlag112-B48","doi-asserted-by":"publisher","first-page":"1383","DOI":"10.1111\/ene.12191","article-title":"ANO5-muscular dystrophy: clinical, pathological and molecular findings","volume":"20","author":"Liewluck","year":"2013","journal-title":"Eur J Neurol"},{"key":"2026102213221687500_nlag112-B49","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1002\/mus.21650","article-title":"Novel diagnostic features of dysferlinopathies","volume":"42","author":"Rosales","year":"2010","journal-title":"Muscle Nerve"},{"key":"2026102213221687500_nlag112-B50","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.nmd.2011.07.005","article-title":"Amyloidosis and exercise intolerance in ANO5 muscular dystrophy","volume":"22","author":"Milone","year":"2012","journal-title":"Neuromuscul Disord"},{"key":"2026102213221687500_nlag112-B51","doi-asserted-by":"publisher","first-page":"e214101","DOI":"10.1212\/WNL.0000000000214101","article-title":"Clinicopathologic features, pathogenesis, and treatment of monoclonal gammopathy-associated myopathies","volume":"105","author":"Soontrapa","year":"2025","journal-title":"Neurology"},{"key":"2026102213221687500_nlag112-B52","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1016\/S0046-8177(98)90061-2","article-title":"Amyloid myopathy: clinicopathologic study of 16 cases","volume":"29","author":"Prayson","year":"1998","journal-title":"Hum Pathol"},{"key":"2026102213221687500_nlag112-B53","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1016\/j.nmd.2022.03.006","article-title":"Coexisting sporadic late onset nemaline myopathy and AL amyloid myopathy\u2013incidental or related?","volume":"32","author":"Moshe-Lilie","year":"2022","journal-title":"Neuromuscul Disord"},{"key":"2026102213221687500_nlag112-B54","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1002\/mus.27362","article-title":"Interstitial amyloidosis in sporadic inclusion body myositis","volume":"64","author":"Alamr","year":"2021","journal-title":"Muscle Nerve"},{"key":"2026102213221687500_nlag112-B55","doi-asserted-by":"publisher","first-page":"H2305","DOI":"10.1152\/ajpheart.00503.2011","article-title":"Human microvascular dysfunction and apoptotic injury induced by AL amyloidosis light chain proteins","volume":"301","author":"Migrino","year":"2011","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"2026102213221687500_nlag112-B56","doi-asserted-by":"publisher","first-page":"4188","DOI":"10.1073\/pnas.0912263107","article-title":"Amyloidogenic light chains induce cardiomyocyte contractile dysfunction and apoptosis via a non-canonical p38\u03b1 MAPK pathway","volume":"107","author":"Shi","year":"2010","journal-title":"Proc Natl Acad Sci USA"},{"key":"2026102213221687500_nlag112-B57","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1007\/BF00695574","article-title":"Systemic amyloid myopathy\u2013light-microscopic and fine-structural study of the skeletal muscles with histochemical and immunohistochemical study of amyloid","volume":"64","author":"Ii","year":"1984","journal-title":"Acta Neuropathol"},{"key":"2026102213221687500_nlag112-B58","doi-asserted-by":"publisher","first-page":"1353","DOI":"10.1136\/jnnp.50.10.1353","article-title":"Proximal weakness of the extremities as main feature of amyloid myopathy","volume":"50","author":"Jennekens","year":"1987","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"2026102213221687500_nlag112-B59","doi-asserted-by":"publisher","first-page":"8","DOI":"10.3109\/13506129.2012.674987","article-title":"Interaction between amyloid fibril formation and extracellular matrix in the proceedings of VIIIth International Symposium on familial amyloidotic polyneuropathy","volume":"19","author":"Misumi","year":"2012","journal-title":"Amyloid"},{"key":"2026102213221687500_nlag112-B60","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1007\/s40120-020-00210-7","article-title":"Transthyretin amyloidosis: update on the clinical spectrum, pathogenesis, and disease-modifying therapies","volume":"9","author":"Koike","year":"2020","journal-title":"Neurol Ther"},{"key":"2026102213221687500_nlag112-B61","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1002\/mus.26723","article-title":"Transthyretin amyloidosis: putting myopathy on the map","volume":"61","author":"Pinto","year":"2020","journal-title":"Muscle Nerve"},{"key":"2026102213221687500_nlag112-B62","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1016\/j.nmd.2006.06.004","article-title":"Amyloid myopathy presenting with rhabdomyolysis: evidence of complement activation","volume":"16","author":"Rodolico","year":"2006","journal-title":"Neuromuscul Disord"},{"key":"2026102213221687500_nlag112-B63","doi-asserted-by":"publisher","first-page":"1891","DOI":"10.1093\/brain\/aww122","article-title":"Microvascular alterations and the role of complement in dermatomyositis","volume":"139","author":"Lahoria","year":"2016","journal-title":"Brain"},{"key":"2026102213221687500_nlag112-B64","doi-asserted-by":"publisher","first-page":"816236","DOI":"10.3389\/fcvm.2022.816236","article-title":"Case report: systemic amyloidosis involving the heart and skeletal muscle","volume":"9","author":"Lv","year":"2022","journal-title":"Front Cardiovasc Med"},{"key":"2026102213221687500_nlag112-B65","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1093\/jnen\/nlz029","article-title":"Neurogenic muscle biopsy findings are common in mitochondrial myopathy","volume":"78","author":"Lu","year":"2019","journal-title":"J Neuropathol Exp Neurol"},{"key":"2026102213221687500_nlag112-B66","doi-asserted-by":"publisher","first-page":"113379","DOI":"10.1016\/j.expneurol.2020.113379","article-title":"Cellular and molecular features of neurogenic skeletal muscle atrophy","volume":"331","author":"Ehmsen","year":"2020","journal-title":"Exp Neurol"},{"key":"2026102213221687500_nlag112-B67","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1002\/mus.26914","article-title":"Myopathies with finger flexor weakness: not only inclusion-body myositis","volume":"62","author":"Nicolau","year":"2020","journal-title":"Muscle Nerve"},{"key":"2026102213221687500_nlag112-B68","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1136\/jnnp.60.6.655","article-title":"Myopathy in primary systemic amyloidosis","volume":"60","author":"Gertz","year":"1996","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"2026102213221687500_nlag112-B69","doi-asserted-by":"publisher","first-page":"1954","DOI":"10.1002\/1529-0131(200108)44:8&lt;1954::AID-ART333&gt;3.0.CO;2-S","article-title":"A deceptive case of amyloid myopathy: clinical and magnetic resonance imaging features","volume":"44","author":"Hull","year":"2001","journal-title":"Arthritis Rheum"},{"key":"2026102213221687500_nlag112-B70","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1111\/j.1085-9489.2004.09405.x","article-title":"Amyloid neuropathy: a retrospective study of 35 peripheral nerve biopsies","volume":"9","author":"Vital","year":"2004","journal-title":"J Peripher Nerv Syst"},{"key":"2026102213221687500_nlag112-B71","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1016\/S1474-4422(22)00432-X","article-title":"Carpal tunnel syndrome: updated evidence and new questions","volume":"22","author":"Padua","year":"2023","journal-title":"Lancet Neurol"},{"key":"2026102213221687500_nlag112-B72","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.jaapos.2019.11.003","article-title":"Isolated orbital amyloidosis causing internal and external ophthalmoplegia","volume":"24","author":"Dodd","year":"2020","journal-title":"J AAPOS"},{"key":"2026102213221687500_nlag112-B73","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1002\/mus.22049","article-title":"Primary amyloidosis presenting as \u201cdropped head syndrome","volume":"43","author":"Chuquilin","year":"2011","journal-title":"Muscle Nerve"},{"key":"2026102213221687500_nlag112-B74","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1001\/jama.2024.0442","article-title":"Cardiac amyloidosis due to transthyretin protein: a review","volume":"331","author":"Ruberg","year":"2024","journal-title":"JAMA"},{"key":"2026102213221687500_nlag112-B75","doi-asserted-by":"publisher","first-page":"30","DOI":"10.3109\/13506129.2012.674076","article-title":"Familial amyloidotic polyneuropathy type IV \u2013 gelsolin amyloidosis","volume":"19","author":"Pihlamaa","year":"2012","journal-title":"Amyloid"},{"key":"2026102213221687500_nlag112-B76","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1080\/13506129.2018.1436048","article-title":"Monoclonal gammopathy of undetermined significance in systemic transthyretin amyloidosis (ATTR)","volume":"25","author":"Phull","year":"2018","journal-title":"Amyloid"},{"key":"2026102213221687500_nlag112-B77","doi-asserted-by":"publisher","first-page":"S13","DOI":"10.1016\/j.amjmed.2022.01.006","article-title":"Neuromuscular complications of systemic amyloidosis","volume":"135","author":"Namiranian","year":"2022","journal-title":"Am J Med."},{"key":"2026102213221687500_nlag112-B78","doi-asserted-by":"publisher","first-page":"1852","DOI":"10.1016\/j.mayocp.2020.06.029","article-title":"Amyloid typing by mass spectrometry in clinical practice: a comprehensive review of 16,175 samples","volume":"95","author":"Dasari","year":"2020","journal-title":"Mayo Clin Proc"},{"key":"2026102213221687500_nlag112-B79","doi-asserted-by":"publisher","first-page":"1239","DOI":"10.3324\/haematol.2013.102764","article-title":"Clinical diagnosis and typing of systemic amyloidosis in subcutaneous fat aspirates by mass spectrometry-based proteomics","volume":"99","author":"Vrana","year":"2014","journal-title":"Haematologica"},{"key":"2026102213221687500_nlag112-B80","doi-asserted-by":"publisher","DOI":"10.3390\/genes12111786","article-title":"Muscle MRI as a useful biomarker in hereditary transthyretin amyloidosis: a pilot study","volume":"12","author":"Primiano","year":"2021","journal-title":"Genes (Basel)"},{"key":"2026102213221687500_nlag112-B81","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1002\/(sici)1097-4598(199903)22:3&lt;355::aid-mus8&gt;3.0.co;2-8","article-title":"Electrophysiologic findings in amyloid myopathy","volume":"22","author":"Rubin","year":"1999","journal-title":"Muscle Nerve"},{"key":"2026102213221687500_nlag112-B82","doi-asserted-by":"publisher","first-page":"4311","DOI":"10.1182\/bloodadvances.2025016586","article-title":"From CyBorD to dara-CyBorD, ASCT utilization trends in AL amyloidosis: a 15-year analysis","volume":"9","author":"Muchtar","year":"2025","journal-title":"Blood Adv"},{"key":"2026102213221687500_nlag112-B83","doi-asserted-by":"publisher","first-page":"101207","DOI":"10.1016\/j.blre.2024.101207","article-title":"Current status and prospect of anti-amyloid fibril therapy in AL amyloidosis","volume":"66","author":"Wang","year":"2024","journal-title":"Blood Rev"},{"key":"2026102213221687500_nlag112-B84","doi-asserted-by":"publisher","first-page":"2111","DOI":"10.1182\/blood-2016-11-751628","article-title":"Improved outcomes for newly diagnosed AL amyloidosis between 2000 and 2014: cracking the glass ceiling of early death","volume":"129","author":"Muchtar","year":"2017","journal-title":"Blood"},{"key":"2026102213221687500_nlag112-B85","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1002\/mus.27740","article-title":"pyrophosphate bone scan: a potential biomarker for the burden of transthyretin amyloidosis in skeletal muscle: a preliminary study","volume":"67","author":"Wlodarski","year":"2023","journal-title":"Muscle Nerve"},{"key":"2026102213221687500_nlag112-B86","doi-asserted-by":"publisher","first-page":"1736","DOI":"10.3390\/genes13101736","article-title":"Anoctamin 5 (ANO5) muscle disorders: a narrative review","volume":"13","author":"Soontrapa","year":"2022","journal-title":"Genes (Basel)"}],"container-title":["Journal of Neuropathology &amp; Experimental Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jnen\/advance-article-pdf\/doi\/10.1093\/jnen\/nlag112\/72371387\/nlag112.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jnen\/advance-article-pdf\/doi\/10.1093\/jnen\/nlag112\/72371387\/nlag112.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T17:22:23Z","timestamp":1792689743000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jnen\/advance-article\/doi\/10.1093\/jnen\/nlag112\/8979526"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,22]]},"references-count":86,"URL":"https:\/\/doi.org\/10.1093\/jnen\/nlag112","relation":{},"ISSN":["0022-3069","1554-6578"],"issn-type":[{"value":"0022-3069","type":"print"},{"value":"1554-6578","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,22]]},"article-number":"nlag112"}}